Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Molecular Cancer Research : MCR|November 8, 2018
High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of <i>GPR126</i> in Bladder CancerSimon Garinet, Géraldine Pignot, Sophie Vacher, et al.
Histopathology|March 15, 2018
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breastGuillaume Bataillon, Laetitia Fuhrmann, Elodie Girard, et al.
British Journal of Cancer|June 15, 2018
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinomaAstrid Lièvre, Bérèngere Ouine, Jim Canet, et al.
BMC Medical Genetics|December 1, 2006
Identification of the first intragenic deletion of the PITX2 gene causing an Axenfeld-Rieger Syndrome: case reportGuillaume de la Houssaye, Ivan Bieche, Olivier Roche, et al.
Molecular Cancer Therapeutics|April 22, 2010
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cellsMaria Serova, Lucile Astorgues-Xerri, Ivan Bieche, et al.
Thrombosis and Haemostasis|August 9, 2014
Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathwayDavid M Smadja, Peter Dorfmüller, Coralie L Guerin, et al.
BMC Cancer|March 15, 2014
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalingsIvan Bieche, Sophie Vacher, David Vallerand, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2014
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesisLucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
British Journal of Cancer|October 13, 2017
Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinomaAstrid Lièvre, Bérèngere Ouine, Jim Canet, et al.
Cancer Research|May 7, 2009
Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cellsAïda Ghoul, Maria Serova, Lucile Astorgues-Xerri, et al.
Pageof 16